Ask Finn← Discover
HEALTH & WELLNESS

Harvard Grew Tiny Lab Brains for Seven Years and They Aged Like the Real Thing

By Jamie Sullivan · Wednesday, August 26, 2026
Finn's Take· TL;DR
  • Harvard scientists kept human brain organoids alive for up to seven years, tripling the previous record and showing cells track developmental time like real brains.
  • Lab-grown brain clusters demonstrated cellular "memory" of their age through genetic markers, with older cells continuing maturation patterns when transplanted to younger organoids.
  • Extended organoid development enables study of late-stage brain disorders like autism and schizophrenia previously only observable in scarce donated tissue samples.
See this from any side — with sources:
Left takeNeutralRight take

A Record-Breaking Experiment Seven Years in the Making

Scientists have kept human brain organoids alive and maturing in the laboratory for more than five years — some even reaching seven years — setting a new longevity record and showing that these tiny clusters of cells track the passage of time much like a developing human brain. The findings, published on August 19 in the journal Nature, represent a landmark moment in neuroscience that could reshape how researchers study the most complex organ in the human body.

The peppercorn-sized clumps of brain cells — each containing more than one million cerebral cortex cells derived from human donors — were sustained in the lab for more than five years, three times longer than the previous record. The previous record for the oldest grown brain organoids was a little under two years. The team behind the breakthrough was led by Paola Arlotta, a Harvard University professor and senior author of the study.

What Does It Mean to "Record the Passage of Time"?

The study, published in the journal Nature, said the organoids "recorded the passage of time and retain a memory of the developmental steps already performed." That's a striking claim, but it doesn't mean these lab-grown brain clusters are conscious or storing memories the way humans do. This does not mean organoids have memories like we tend to think of them — such as recalling something from childhood — but simply that their past is "engraved" on a cellular level.

To confirm this, the authors transferred neurons from older to younger organoids and gauged their response to the new environment. Despite receiving signals telling them otherwise, the older cells continued progressing as if they were still housed in their prior organoids, skipping developmental steps compared with their younger neighbors. In other words, the cells knew how old they were — and acted accordingly. Three independent genetic and epigenetic clocks showed the organoids matured on a schedule that closely tracked human postnatal brain development, not an accelerated lab timetable.

Why This Matters for Brain Disease Research

These tiny clumps called organoids are grown from stem cells by scientists around the world in the hope of uncovering the mysteries of our brains — and to test new medicines without having to use animals such as mice. Normally, these organoids live for a few months, meaning they can offer only a window into the earliest stages of human brains, which take nearly 20 years to fully develop. That limitation has long frustrated researchers trying to understand what goes wrong in conditions that emerge later in development.

These later periods are especially relevant to schizophrenia, epilepsy, severe autism, and a host of other disorders. Scientists have studied late-stage development using donated tissue, but samples are scarce and raise ethical concerns. As one NIH official noted, "the unprecedented longevity and lifelike qualities of these tissue models could afford us the opportunity to dig deeper into how conditions such as autism emerge and unfold later in life."

What Comes Next

Maintaining these fragile cell cultures over many years is difficult and expensive, and there are no plans to continue purely for the sake of setting a new longevity record. Instead, the team seeks to target key phases by pursuing the "time warp" capability. The goal, Arlotta has explained, is not simply to see how long these organoids can survive, but to harness what's already been proven possible.

In the future, it could be possible to use this technique to rapidly speed up the development of certain brain cells, Arlotta speculated. Organoids cultured over extended timelines, and the wealth of multimodal data produced from them, represent both a powerful experimental system and a source of information to fuel understanding of the largely unexplored mechanisms governing human brain maturation and evolution. For the millions of people living with neurological and psychiatric disorders — and the researchers racing to help them — that prospect is anything but small.

Have a question about this story?
Ask Finn — answers grounded in this article, from any viewpoint.